Four abstracts at SITC 2024 feature TIMING data featuring CellChorus®
HOUSTON, Texas — November 4, 2024. CellChorus®, the dynamic single-cell analysis company™, today announced that four abstracts have been accepted for presentation at the Society for Immunotherapy of Cancer (SITC) Annual Meeting featuring data from the CellChorus Time-lapse Imaging Microscopy... Read More →
Bright Uro Announces Oversubscribed $32M Series A Funding Round
Laborie, University of California (UC Investments), Freepoint Capital and Laurelin Investors deliver funding to power 2025 product launch IRVINE, Calif., Oct. 31, 2024 /PRNewswire/ — Bright Uro, a medical device company with a mission to transform care for lower urinary tract symptoms (LUTS) through innovations... Read More →
Telix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®
MELBOURNE, Australia, Oct. 30, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a partnership with California-based Subtle Medical, Inc. (Subtle Medical) for artificial intelligence (AI)-powered positron emission tomography (PET) imaging with Telix’s commercial PSMA-PET1... Read More →
2024 Startup Battlefield Top 20 Finalists: MDC | TechCrunch Disrupt 2024
MDC is revolutionizing surgery with a novel robotic system that provides physicians direct access inside MRI scanners. Watch
InBrain Neuroelectronics raises $50M Series B to support BCI
InBrain Neuroelectronics announced today that it closed a Series B financing round with proceeds totaling $50 million. The Barcelona, Spain-based company also secured additional funding and support from Merck KGaA. This goes toward the clinical development of its technology in... Read More →
Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform
DUBLIN, Oct. 25, 2024 (GLOBE NEWSWIRE) — Trinity Biotech plc (TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic investment in Novus Diagnostics, a company pioneering a rapid sepsis... Read More →
Deephealth Expands Its AI-Powered Cancer Diagnostic and Screening Portfolio with the Acquisition of Kheiron
DeepHealth has acquired Kheiron Medical Technologies Limited, a UK-based AI cancer diagnostic company focused on developing deep learning solutions to support radiologists improve breast cancer detection. Kheiron’s Mia® (Mammography Intelligent Assessment) suite of AI solutions for breast cancer screening is... Read More →
Loop Earplugs, UBlockout, and Neurovalens Win National Sleep Foundation’s 2024 SleepTech® Award
WASHINGTON, Oct. 22, 2024 /PRNewswire/ — The National Sleep Foundation (NSF) named Loop Earplugs, UBlockout, and Neurovalens as winners of the 2024 SleepTech® Award. NSF’s SleepTech Award recognizes the year’s most innovative efforts in advancing sleep technology and is a... Read More →
Cancer Discovery publication applies TIMING to show increased serial killing by novel CAR NK therapy
CAR27 NK cells with CD28-based costimulation resulted in significantly better long-term cytotoxicity, polyfunctionality, and survival in animals HOUSTON, Texas — October 21, 2024. CellChorus®, the dynamic single-cell analysis company™, announced that authors from the University of Texas MD Anderson... Read More →
Release: NIH announces winners of prize competition to improve postpartum maternal health and health equity through innovative diagnostics featuring CardieX, Caretaker Medical, Sibel Health, and PyrAmes
The National Institutes of Health (NIH) has announced the winners of the Rapid Acceleration of Diagnostics Technology (RADx® Tech) for Maternal Health Challenge, an $8 million prize competition to encourage development of postpartum maternal health diagnostics for use in regions... Read More →